Satellite Bio

Thank you to the Alliance for Regenerative Medicine for welcoming me to the Women’s Executive Forum!    I’m thrilled to join this community dedicated to fostering collaboration and connection among female C-suite executives in the cell and gene therapy sector.    I look forward to learning from fellow leaders, and to contributing to this important community. 

Satty colleagues had a blast at Trombetta's Farm for Satellite Bio's summer outing! The food was delicious, the company was excellent, and the mini golf competition? That was fierce. This well-deserved day was also an important reminder that achieving our big ambitions – unlocking the full potential of liver cells as medicine – requires that we take time to connect and recharge together. At Satellite, we know the importance of balancing hard work with fun! 

We are thrilled to welcome our most recent cohort of Northeastern University co-op students to the Satellite Bio family! Anna Decker, Paige Harrington, and Emma Drumm - it is great to have you on board. We look forward to seeing the impact you will make during your time with us as we work to bring #tissuetherapeutics to patients in need. As part of our commitment to mentorship and development, we look forward to providing you with valuable experiences and learning opportunities.

Last week, I had the privilege of participating in the Convergence Forum, a dynamic gathering of leaders coming together to discuss and debate the most pressing topics of the modern healthcare industry. Here’s what rose to the top: ·   The path to the biotech recovery has been anything but linear, with promising starts and sputtering stops. It was valuable to hear how tenured investors are thinking and operating in this market, including the perspectives of Satellite Bio board member, Steve Kafka of S32, and Amir Nashat from Polaris Partners – both early investors in Satellite, alongside Christine Brennan from Vertex Ventures HC.  Thanks Michael Gilman for an excellent panel! ·      In a similar vein, I appreciated a robust discussion around the tricky, but nevertheless important, topic of how to think about strategic options when it seems you’ve reached the end of the line. Spearheading a dialogue on difficult topics requires courage, and this all-woman panel of deeply experienced, incredible leaders earned their mettle. Thank you for showing us the way, Jodie Morrison (She/Her), Rosemary Reilly and Marian Nakada, Ph.D.. ·      And speaking of creative thinking, Peter Kolchinsky of RA Capital Management led a hands-on workshop that had us examine our role in reversing the public apathy that is driving anti-innovation policy. Without us, the literal leaders of innovation, effectively articulating the immense value we deliver by protecting and advancing public health, we will fail to impact real policy-level change. From learning from other’s hard-earned insights, to building important relationship and gathering practical advice, it was a thought-provoking two days that provided a great pulse on what’s happening across our sector. Thanks for having me Convergence Forum, I’m already looking forward to next year! Also in the pictures Mahesh Karande, Michal Preminger, Olga Granaturova, who alongside many other esteemed friends and colleagues participated in this excellent event! #CVFORUM24

A few weeks ago I had the privilege of attending the Massachusetts Institute of Technology Faculty Founder Initiative Showcase as part of the 2023-2024 MIT-Royalty Pharma Prize Competition, a prestigious event celebrating the achievements of twelve esteemed faculty members from MIT and Brown University. A few thoughts: -At its core, the program’s aim is to support female faculty entrepreneurs in biotechnology and provide them with resources to help take their ideas to commercialization. According to research conducted in part by Satellite Bio co-founder and faculty director of the initiative, Sangeeta Bhatia, if female faculty founded startups at the same rate as their male counterparts, there would be 40 more biotech companies. Think of the incredible potential for positive impact on human health! -We are talking about truly innovative and groundbreaking ideas. I was blown away by this year’s pitches. Seeing the passion and creativity these women have for their projects was inspiring and energizing. -I loved that some women brought their kids along to the event. What could be more in alignment with the goal of this initiative, especially for little girls? A tangible and important reminder of the need for representation and empowerment at every stage. -One of the most fulfilling aspects of this initiative has been seeing the tangible success of the program. There have been multiple biotechs launched out of the program so far – and I know these budding entrepreneurs are just getting started. As a mentor since its inaugural year, it’s been an honor to contribute to an ecosystem that helps propel promising science forward. I cannot wait to see what this incredible cohort does next. Thanks Sangeeta Bhatia and Kit Hickey for allowing me to be part of such a wonderful initiative!

Today Satellite Bio will present new preclinical data at the American Society of Gene & Cell Therapy Annual Meeting demonstrating our ability to generate a sustainable source of primary cell-derived hepatocytes that expand, mature and function like primary hepatocytes. Read our press release here to learn more: https://shorturl.at/jsvzI #ASGCT2024 Alireza Rezania Laura Lande-Diner Tom Lowery Arnav Chhabra

At Satellite Bio we Relish Doing Hard Things Well, a value shared by our neighbors at The Greater Boston Food Bank.   Today, we took a break from pioneering Tissue Therapeutics to roll up our sleeves in support of the work they are doing to create a hunger free Eastern Massachusetts.   From sorting and packing food items for distribution, to hearing directly about the impact on families facing food insecurity, it was an inspiring and rewarding day.   Thank you to The Greater Boston Food Bank for having us! We will be back. 

Satellite Bio President and CTO, Tom Lowery, had his ear to the ground during his time at the Alliance for Regenerative Medicine's #CGMed24 – three themes emerged: 1)    The regenerative medicine sector is hotter than ever. On the heels of an already remarkable year for cell & gene therapies, 2024 could deliver as many as 14 new cell & gene approvals in the US and EU. Watch this space. 2)    Following the path of CAR-T, we are on the cusp of realizing the potential for more complex cell types. It’s inspiring to see where CAR-T is today as compared to where it was 5-10 years ago, particularly as it relates to standardization of CMC, nonclinical and clinical approaches. We will soon see a similar inflection for more complex cell types, like the work we do at Satellite with hepatocytes, which has the potential to deliver an incredible impact for patients. 3)    And speaking of patients – they are waiting. Having the opportunity to hear directly from the people and caregivers whose lives have been changed by regenerative medicines inspires the work we do every day; and is an important reminder to keeping pushing forward. What was your favorite moment from the meeting? And if you’re registered, there is still time to check out Tom’s presentation: https://lnkd.in/eNPPAt3C

Satellite Bio President and CTO, Tom Lowery, had his ear to the ground during his time at the Alliance for Regenerative Medicine's #CGMed24 – three themes emerged: 1)    The regenerative medicine sector is hotter than ever. On the heels of an already remarkable year for cell & gene therapies, 2024 could deliver as many as 14 new cell & gene approvals in the US and EU. Watch this space. 2)    Following the path of CAR-T, we are on the cusp of realizing the potential for more complex cell types. It’s inspiring to see where CAR-T is today as compared to where it was 5-10 years ago, particularly as it relates to standardization of CMC, nonclinical and clinical approaches. We will soon see a similar inflection for more complex cell types, like the work we do at Satellite with hepatocytes, which has the potential to deliver an incredible impact for patients. 3)    And speaking of patients – they are waiting. Having the opportunity to hear directly from the people and caregivers whose lives have been changed by regenerative medicines inspires the work we do every day; and is an important reminder to keeping pushing forward. What was your favorite moment from the meeting? And if you’re registered, there is still time to check out Tom’s presentation: https://lnkd.in/eNPPAt3C

Today is Day 3 of the Alliance for Regenerative Medicine's 2024 Cell & Gene Meeting on the Med! Don't miss Tom Lowery's presentation and panel showcasing Satellite Bio's most recent progress updates and make sure to check out Check out the full lineup of speakers and presentations at https://lnkd.in/eUTEuU7